Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities

Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities

Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pediatric gastroenterology and nutrition 2020-06, Vol.70 (6), p.796
Hauptverfasser: Singh, Harveen, Coffey, Michael J, Ooi, Chee Y
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 6
container_start_page 796
container_title Journal of pediatric gastroenterology and nutrition
container_volume 70
creator Singh, Harveen
Coffey, Michael J
Ooi, Chee Y
description Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudinal review (from 1998 to 2016) of severe CFLD patients compared with noCFLD controls (matched 1 : 1 for age, genotype, pancreatic insufficiency, and center). One hundred sixty-six patients with severe CFLD and 166 with noCFLD were identified. Forced expiratory volume in 1 second percentage of predicted (FEV1%) was significantly lower in CFLD than noCFLD across all ages (estimate [SE] -6.05% [2.12]; P = 0.004). Median (IQR) hospitalizations per patient per year were higher in CFLD than noCFLD for: respiratory indications (0.6 [0.2-1.3] vs 0.4 [0.1-0.9]; P = 0.002); gastrointestinal indications (0.09 [0-0.2] vs 0 [0-0.05]; P 
doi_str_mv 10.1097/MPG.0000000000002694
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_32443033</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32443033</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-31fc3f349452c2394be6b87aa35ccb0d7b9ed2b46e8f05ad3b131ade83b726843</originalsourceid><addsrcrecordid>eNpNj8lKA0EURQtBTIz-gUj9QMeqetXTMrZJDLToQnEZaniNT9IDVR0hf-8s3s1dnMOFy9iFFHMpyvzq7mE9F_-islIfsalMIUt0IeSEncb4-gFynYoTNgGlNQiAKWurQxzJ8RXZ0EeKScCdGdHzmt4w8BuKaCJyinwRY-_oiz3T-MI3nQufzP9J1_vgseOm83zZ-d4F6pBXfdsHS55GwnjGjhuzi3j-0zP2tFo-VrdJfb_eVIs6GaQoxgRk46ABXepUOQWltpjZIjcGUues8Lkt0SurMywakRoPVoI0HguwucoKDTN2-b077G2LfjsEak04bH9_wzvHcVqW</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities</title><source>Wiley Online Library All Journals</source><creator>Singh, Harveen ; Coffey, Michael J ; Ooi, Chee Y</creator><creatorcontrib>Singh, Harveen ; Coffey, Michael J ; Ooi, Chee Y</creatorcontrib><description>Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudinal review (from 1998 to 2016) of severe CFLD patients compared with noCFLD controls (matched 1 : 1 for age, genotype, pancreatic insufficiency, and center). One hundred sixty-six patients with severe CFLD and 166 with noCFLD were identified. Forced expiratory volume in 1 second percentage of predicted (FEV1%) was significantly lower in CFLD than noCFLD across all ages (estimate [SE] -6.05% [2.12]; P = 0.004). Median (IQR) hospitalizations per patient per year were higher in CFLD than noCFLD for: respiratory indications (0.6 [0.2-1.3] vs 0.4 [0.1-0.9]; P = 0.002); gastrointestinal indications (0.09 [0-0.2] vs 0 [0-0.05]; P &lt; 0.001); and other indications (0.05 [0-0.2] vs 0 [0-0.1]; P = 0.03). In the CFLD cohort, there was increased use of nasogastric (12.6% vs 5.4%; OR 2.51 [95% CI 1.06-6.46]; P = 0.03) and gastrostomy nutritional supplementation (22.9% vs 13.2%; OR 1.93 [95% CI 1.05-3.63]; P = 0.03). Additionally, the CFLD cohort had a higher frequency of bone diseases, osteopenia (26.5% vs 16.8%; OR 1.77 [95%CI 1.01-3.15]; P = 0.04) and osteoporosis (16.2% vs 8.4%; OR 2.1 [95% CI 1.01-4.52]; P = 0.04), as well as CF-related diabetes (38.5% vs 19.2%; OR 2.61 [95% CI 1.55-4.47]; P = 0.001). Patients with severe CFLD have greater disease burden, with higher number of hospitalizations (both respiratory and nonrespiratory indications), nutritional interventions, and are at higher risk of CF-related bone disease and diabetes.</description><identifier>EISSN: 1536-4801</identifier><identifier>DOI: 10.1097/MPG.0000000000002694</identifier><identifier>PMID: 32443033</identifier><language>eng</language><publisher>United States</publisher><ispartof>Journal of pediatric gastroenterology and nutrition, 2020-06, Vol.70 (6), p.796</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32443033$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Singh, Harveen</creatorcontrib><creatorcontrib>Coffey, Michael J</creatorcontrib><creatorcontrib>Ooi, Chee Y</creatorcontrib><title>Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities</title><title>Journal of pediatric gastroenterology and nutrition</title><addtitle>J Pediatr Gastroenterol Nutr</addtitle><description>Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudinal review (from 1998 to 2016) of severe CFLD patients compared with noCFLD controls (matched 1 : 1 for age, genotype, pancreatic insufficiency, and center). One hundred sixty-six patients with severe CFLD and 166 with noCFLD were identified. Forced expiratory volume in 1 second percentage of predicted (FEV1%) was significantly lower in CFLD than noCFLD across all ages (estimate [SE] -6.05% [2.12]; P = 0.004). Median (IQR) hospitalizations per patient per year were higher in CFLD than noCFLD for: respiratory indications (0.6 [0.2-1.3] vs 0.4 [0.1-0.9]; P = 0.002); gastrointestinal indications (0.09 [0-0.2] vs 0 [0-0.05]; P &lt; 0.001); and other indications (0.05 [0-0.2] vs 0 [0-0.1]; P = 0.03). In the CFLD cohort, there was increased use of nasogastric (12.6% vs 5.4%; OR 2.51 [95% CI 1.06-6.46]; P = 0.03) and gastrostomy nutritional supplementation (22.9% vs 13.2%; OR 1.93 [95% CI 1.05-3.63]; P = 0.03). Additionally, the CFLD cohort had a higher frequency of bone diseases, osteopenia (26.5% vs 16.8%; OR 1.77 [95%CI 1.01-3.15]; P = 0.04) and osteoporosis (16.2% vs 8.4%; OR 2.1 [95% CI 1.01-4.52]; P = 0.04), as well as CF-related diabetes (38.5% vs 19.2%; OR 2.61 [95% CI 1.55-4.47]; P = 0.001). Patients with severe CFLD have greater disease burden, with higher number of hospitalizations (both respiratory and nonrespiratory indications), nutritional interventions, and are at higher risk of CF-related bone disease and diabetes.</description><issn>1536-4801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpNj8lKA0EURQtBTIz-gUj9QMeqetXTMrZJDLToQnEZaniNT9IDVR0hf-8s3s1dnMOFy9iFFHMpyvzq7mE9F_-islIfsalMIUt0IeSEncb4-gFynYoTNgGlNQiAKWurQxzJ8RXZ0EeKScCdGdHzmt4w8BuKaCJyinwRY-_oiz3T-MI3nQufzP9J1_vgseOm83zZ-d4F6pBXfdsHS55GwnjGjhuzi3j-0zP2tFo-VrdJfb_eVIs6GaQoxgRk46ABXepUOQWltpjZIjcGUues8Lkt0SurMywakRoPVoI0HguwucoKDTN2-b077G2LfjsEak04bH9_wzvHcVqW</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Singh, Harveen</creator><creator>Coffey, Michael J</creator><creator>Ooi, Chee Y</creator><scope>NPM</scope></search><sort><creationdate>202006</creationdate><title>Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities</title><author>Singh, Harveen ; Coffey, Michael J ; Ooi, Chee Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-31fc3f349452c2394be6b87aa35ccb0d7b9ed2b46e8f05ad3b131ade83b726843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Harveen</creatorcontrib><creatorcontrib>Coffey, Michael J</creatorcontrib><creatorcontrib>Ooi, Chee Y</creatorcontrib><collection>PubMed</collection><jtitle>Journal of pediatric gastroenterology and nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Harveen</au><au>Coffey, Michael J</au><au>Ooi, Chee Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities</atitle><jtitle>Journal of pediatric gastroenterology and nutrition</jtitle><addtitle>J Pediatr Gastroenterol Nutr</addtitle><date>2020-06</date><risdate>2020</risdate><volume>70</volume><issue>6</issue><spage>796</spage><pages>796-</pages><eissn>1536-4801</eissn><abstract>Cystic fibrosis-related liver disease (CFLD) is the leading nonpulmonary cause of mortality in cystic fibrosis (CF). We evaluated and compared the burden of disease and nonrespiratory comorbidities of those with severe CFLD and those without (noCFLD). A retrospective nationwide (Australia) longitudinal review (from 1998 to 2016) of severe CFLD patients compared with noCFLD controls (matched 1 : 1 for age, genotype, pancreatic insufficiency, and center). One hundred sixty-six patients with severe CFLD and 166 with noCFLD were identified. Forced expiratory volume in 1 second percentage of predicted (FEV1%) was significantly lower in CFLD than noCFLD across all ages (estimate [SE] -6.05% [2.12]; P = 0.004). Median (IQR) hospitalizations per patient per year were higher in CFLD than noCFLD for: respiratory indications (0.6 [0.2-1.3] vs 0.4 [0.1-0.9]; P = 0.002); gastrointestinal indications (0.09 [0-0.2] vs 0 [0-0.05]; P &lt; 0.001); and other indications (0.05 [0-0.2] vs 0 [0-0.1]; P = 0.03). In the CFLD cohort, there was increased use of nasogastric (12.6% vs 5.4%; OR 2.51 [95% CI 1.06-6.46]; P = 0.03) and gastrostomy nutritional supplementation (22.9% vs 13.2%; OR 1.93 [95% CI 1.05-3.63]; P = 0.03). Additionally, the CFLD cohort had a higher frequency of bone diseases, osteopenia (26.5% vs 16.8%; OR 1.77 [95%CI 1.01-3.15]; P = 0.04) and osteoporosis (16.2% vs 8.4%; OR 2.1 [95% CI 1.01-4.52]; P = 0.04), as well as CF-related diabetes (38.5% vs 19.2%; OR 2.61 [95% CI 1.55-4.47]; P = 0.001). Patients with severe CFLD have greater disease burden, with higher number of hospitalizations (both respiratory and nonrespiratory indications), nutritional interventions, and are at higher risk of CF-related bone disease and diabetes.</abstract><cop>United States</cop><pmid>32443033</pmid><doi>10.1097/MPG.0000000000002694</doi></addata></record>
fulltext fulltext
identifier EISSN: 1536-4801
ispartof Journal of pediatric gastroenterology and nutrition, 2020-06, Vol.70 (6), p.796
issn 1536-4801
language eng
recordid cdi_pubmed_primary_32443033
source Wiley Online Library All Journals
title Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T23%3A33%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cystic%20Fibrosis-related%20Liver%20Disease%20is%20Associated%20With%20Increased%20Disease%20Burden%20and%20Endocrine%20Comorbidities&rft.jtitle=Journal%20of%20pediatric%20gastroenterology%20and%20nutrition&rft.au=Singh,%20Harveen&rft.date=2020-06&rft.volume=70&rft.issue=6&rft.spage=796&rft.pages=796-&rft.eissn=1536-4801&rft_id=info:doi/10.1097/MPG.0000000000002694&rft_dat=%3Cpubmed%3E32443033%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32443033&rfr_iscdi=true